Skip to main content

Medicinal Chemistry and Ligand Profiling for Evaluation of Promising Marine Bioactive Molecules

  • Chapter
  • First Online:
Marine Bioactive Compounds

Abstract

Many marine natural products exhibit a range of bioactivities, including anticancer, antiviral, antifungal, and antihypertensive properties. As such, they are excellent lead compounds for further drug discovery. In recent years, due to the more accessible cost of computing in terms of both money and time, the complex and expensive process of drug discovery has been significantly enhanced through the use of computational approaches. Here we describe key aspects of the process where computation has helped, including lead validation, optimization, profiling, and discovery, as well as in silico ADME (absorption, distribution, metabolism, and elimination) and toxicological methods, giving relevant examples of the uses of such approaches from the marine natural product world.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abraham, I., S. Jain, C.P. Wu, M.A. Khanfar, Y. Kuang, C.L. Dai, Z. Shi, X. Chen, L. Fu, S.V. Ambudkar, K. El Sayed, and Z.S. Chen. 2010. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Biochemical Pharmacology 80: 1497–1506.

    Article  PubMed  CAS  Google Scholar 

  • Andersen, R.J., D.J. Faulkner, C.H. He, G.D. Van Duyne, and J. Clardy. 1985. Metabolites of the marine prosobranch mollusk Lamellaria sp. Journal of the American Chemical Society 107: 5492–5495.

    Article  CAS  Google Scholar 

  • Babu, P.A., S.S. Puppala, S.L. Aswini, M.R. Vani, C.N. Kumar, and T. Prasanna. 2008. A database of natural products and chemical entities from marine habitat. Bioinformation 3: 142–143.

    PubMed  Google Scholar 

  • Baunbaek, D., N. Trinkler, Y. Ferandin, O. Lozach, P. Ploypradith, S. Rucirawat, F. Ishibashi, M. Iwao, and L. Meijer. 2008. Anticancer alkaloid lamellarins inhibit protein kinases. Marine Drugs 6: 514–527.

    Article  PubMed  CAS  Google Scholar 

  • Beierlein, F., H. Lanig, G. Schurer, A.H.C. Horn, and T. Clark. 2003. Quantum mechanical/molecular mechanical (QM/MM) docking: An evaluation for known test systems. Molecular Physics 101: 2469–2480.

    Article  CAS  Google Scholar 

  • Belden, H. 2005. First pain drug in new class comes from snail. Drug Topics 149: 8.

    Google Scholar 

  • Bissantz, C., G. Folkers, and D. Rognan. 2000. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. Journal of Medicinal Chemistry 43: 4759–4767.

    Article  PubMed  CAS  Google Scholar 

  • Blundell, T.L., H. Jhoti, and C. Abell. 2002. High-throughput crystallography for lead discovery in drug design. Nature Reviews Drug Discovery 1: 45–54.

    Article  PubMed  CAS  Google Scholar 

  • Boldi, A.M. 2004. Libraries from natural product-like scaffolds. Current Opinion in Chemical Biology 8: 281–286.

    Article  PubMed  CAS  Google Scholar 

  • Bradley, J.C., C. Neylon, R. Guha, A.J. Williams, B. Hooker, A.S.I.D. Lang, B. Friesen, T. Bohinski, D. Bulger, M. Federici, J. Hale, J. Mancinelli, K.B. Mirza, M.J. Moritz, D. Rein, C. Tchakounte, and H.T. Truong. 2010. Open notebook science challenge: Solubilities of organic compounds in organic solvents. Nature Precedings. doi:10.1038/npre.2010.4243.1033.

  • Bugni, T.S., B. Richards, L. Bhoite, D. Cimbora, M.K. Harper, and C.M. Ireland. 2008. Marine natural product libraries for high-throughput screening and rapid drug discovery. Journal of Natural Products 71: 1095–1098.

    Article  PubMed  CAS  Google Scholar 

  • Butina, D., M.D. Segall, and K. Frankcombe. 2002. Predicting ADME properties in silico: Methods and models. Drug Discovery Today 7: S83–S88.

    Article  PubMed  CAS  Google Scholar 

  • Cavalli, A., M.L. Bolognesi, A. Minarini, M. Rosini, V. Tumiatti, M. Recanatini, and C. Melchiorre. 2008. Multi-target-directed ligands to combat neurodegenerative diseases. Journal of Medicinal Chemistry 51: 347–372.

    Article  PubMed  CAS  Google Scholar 

  • Chong, C.R., and D.J. Sullivan. 2007. New uses for old drugs. Nature 448: 645–646.

    Article  PubMed  CAS  Google Scholar 

  • Clardy, J., and C. Walsh. 2004. Lessons from natural molecules. Nature 432: 829–837.

    Article  PubMed  CAS  Google Scholar 

  • Claudel, T., B. Staels, and F. Kuipers. 2005. The Farnesoid X receptor: A molecular link between bile acid and lipid and glucose metabolism. Arteriosclerosis, Thrombosis, and Vascular Biology 25: 2020–2030.

    Article  PubMed  CAS  Google Scholar 

  • Cole, S.L., and R. Vassar. 2007. The Alzheimer’s disease β-secretase enzyme, BACE1. Molecular Neurodegeneration 2: 22.

    Article  PubMed  CAS  Google Scholar 

  • Congreve, M., R. Carr, C. Murray, and H. Jhoti. 2003. A rule of three for fragment-based lead discovery? Drug Discovery Today 8: 876–877.

    Article  PubMed  Google Scholar 

  • Congreve, M., G. Chessari, D. Tisi, and A.J. Woodhead. 2008. Recent developments in fragment-based drug discovery. Journal of Medicinal Chemistry 51: 3661–3680.

    Article  PubMed  CAS  Google Scholar 

  • Cragg, G.M., S.A. Schepartz, M. Suffness, and M.R. Grever. 1993. The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents. Journal of Natural Products 56: 1657–1668.

    Article  PubMed  CAS  Google Scholar 

  • Davis, A.M., and R.J. Riley. 2004. Predictice ADMET studies, the challenges and the opportunities. Current Opinion in Chemical Biology 8: 378–386.

    Article  PubMed  CAS  Google Scholar 

  • Davis, G.D., and A.H. Vasanthi. 2011. Seaweed metabolite database (SWMD): A database of natural compounds from marine algae. Bioinformation 5: 361–364.

    PubMed  Google Scholar 

  • de Groot, M.J. 2006. Designing better drugs: Predicting cytochrome P450 metabolism. Drug Discovery Today 11: 601–606.

    Article  PubMed  CAS  Google Scholar 

  • Deng, X.Q., H.Y. Wang, Y.L. Zhao, M.L. Xiang, P.D. Jiang, Z.X. Cao, Y.Z. Zheng, S.D. Luo, L.T. Yu, Y.Q. Wei, and S.Y. Yang. 2008. Pharmacophore modelling and virtual screening for identification of new Aurora-A kinase inhibitors. Chemical Biology & Drug Design 71: 533–539.

    Article  CAS  Google Scholar 

  • Dictionary of Natural Products. London: Chapman & Hall/CRC Informa.

    Google Scholar 

  • Do, Q.T., C. Lamy, I. Renimel, N. Sauvan, P. Andre, F. Himbert, L. Morin-Allory, and P. Bernard. 2007. Reverse pharmacognosy: Identifying biological properties for plants by means of their molecule constituents: Application to meranzin. Planta Medica 73: 1235–1240.

    Article  PubMed  CAS  Google Scholar 

  • Dror, O., D. Schneidman-Duhovny, Y. Inbar, R. Nussinov, and H.J. Wolfson. 2009. Novel approach for efficient pharmacophore-based virtual screening: Method and applications. Journal of Chemical Information and Modeling 49: 2333–2343.

    Article  PubMed  CAS  Google Scholar 

  • Eisenhauer, E.A., W.W. ten Bokkel Huinink, K.D. Swenerton, L. Gianni, J. Myles, M.E. van der Burg, I. Kerr, J.B. Vermorken, K. Buser, and N. Colombo. 1994. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion. Journal of Clinical Oncology 12: 2654–2666.

    PubMed  CAS  Google Scholar 

  • Ekins, S., J.D. Honeycutt, and J.T. Metz. 2010. Evolving molecules using multi-objective optimization: Applying to ADME/Tox. Drug Discovery Today 15: 451–460.

    Article  PubMed  CAS  Google Scholar 

  • Eldridge, M.D., C.W. Murray, T.R. Auton, G.V. Paolini, and R.P. Mee. 1997. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. Journal of Computer-Aided Molecular Design 11: 425–445.

    Article  PubMed  CAS  Google Scholar 

  • Erlanson, D.A., R.S. McDowell, and T. O’Brien. 2004. Fragment-based drug discovery. Journal of Medicinal Chemistry 47: 3463–3482.

    Article  PubMed  CAS  Google Scholar 

  • Ertl, P., S. Roggo, and A. Schuffenhauer. 2008. Natural product-likeness score and its application for prioritization of compound libraries. Journal of Chemical Information and Modeling 48: 68–74.

    Article  PubMed  CAS  Google Scholar 

  • Ewing, T.J., S. Makino, A.G. Skillman, and I.D. Kuntz. 2001. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases. Journal of Computer-Aided Molecular Design 15: 411–428.

    Article  PubMed  CAS  Google Scholar 

  • Fanfrlik, J., J. Brynda, J. Rezac, P. Hobza, and M. Lepsik. 2008. Interpretation of protein/ligand crystal structure using QM/MM calculations: Case of HIV-1 protease/metallacarborane complex. Journal of Physical Chemistry B 112: 15094–15102.

    Article  CAS  Google Scholar 

  • Feher, M., and J.M. Schmidt. 2003. Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry. Journal of Chemical Information and Computer Sciences 43: 218–227.

    Article  PubMed  CAS  Google Scholar 

  • Ferrara, P., H. Gohlke, D.J. Price, G. Klebe, and C.L. Brooks III. 2004. Assessing scoring functions for protein. Journal of Medicinal Chemistry 47: 3032–3047.

    Article  PubMed  CAS  Google Scholar 

  • Foster, I., Zhao, Y., Raicu, I., and Lu, S. 2009. Cloud computing and grid computing 360-degree compared. ArXiv e-prints: 0901.0131v0901.

  • Francis, G.A., E. Fayard, F. Picard, and J. Auwerx. 2003. Nuclear receptors and the control of metabolism. Annual Review of Physiology 65: 261–311.

    Article  PubMed  CAS  Google Scholar 

  • FRED. 2008. OpenEye Scientific Software. New Mexico, United States.

    Google Scholar 

  • Gentilucci, L., F. Squassabia, R. Demarco, R. Artali, G. Cardillo, A. Tolomelli, S. Spampinato, and A. Bedini. 2008. Investigation of the interaction between the atypical agonist c[YpwFG] and MOR. Febs Journal 275: 2315–2337.

    Article  PubMed  CAS  Google Scholar 

  • Glaser, K.B., and A.M. Mayer. 2009. A renaissance in marine pharmacology: From preclinical curiosity to clinical reality. Biochemical Pharmacology 78: 440–448.

    Article  PubMed  CAS  Google Scholar 

  • Gleeson, M.P. 2008. Generation of a set of simple, interpretable ADMET rules of thumb. Journal of Medicinal Chemistry 51: 817–834.

    Article  PubMed  CAS  Google Scholar 

  • Gleeson, M.P., and D. Gleeson. 2009. QM/MM calculations in drug discovery: A useful method for studying binding phenomena? Journal of Chemical Information and Modeling 49: 670–677.

    Article  PubMed  CAS  Google Scholar 

  • Gleeson, M.P., S. Hannongbua, and D. Gleeson. 2010. QM methods in structure based design: Utility in probing protein-ligand interactions. Journal of Molecular Graphics and Modelling 29: 507–517.

    Article  PubMed  CAS  Google Scholar 

  • Guner, O.F. 2002. History and evolution of the pharmacophore concept in computer-aided drug design. Current Topics in Medicinal Chemistry 2: 1321–1332.

    Article  PubMed  CAS  Google Scholar 

  • Hai-Lun, H., C. Xiu-Lan, S. Cai-Yun, Z. Yu-Zhong, and Z. Bai-Cheng. 2006. Analysis of novel angiotensin-I-converting enzyme inhibitory peptides from protease-hydrolyzed marine shrimp Acetes chinensis. Journal of Peptide Science 12: 726–733.

    Article  PubMed  CAS  Google Scholar 

  • Halgren, T.A., and W. Damm. 2001. Polarizable force fields. Current Opinion in Structural Biology 11: 236–242.

    Article  PubMed  CAS  Google Scholar 

  • Hardy, B., OpenTox. 2011. Barry Hardy. http://www.opentox.org/. Accessed 3 May 2011.

  • Harriman, D.J., and G. Deslongehamps. 2004. Reverse-docking as a computational tool for the study of asymmetric organocatalysis. Journal of Computer-Aided Molecular Design 18: 303–308.

    Article  PubMed  CAS  Google Scholar 

  • Harvey, A.L. 2007. Natural products as a screening resource. Current Opinion in Chemical Biology 11: 480–484.

    Article  PubMed  CAS  Google Scholar 

  • Haustedt, L.O., C. Mang, K. Siems, and H. Schiewe. 2006. Rational approaches to natural-product-based drug design. Current Opinion in Drug Discovery & Development 9: 445–462.

    CAS  Google Scholar 

  • Hein, M., D. Zilian, and C.A. Sotriffer. 2010. Docking compared to 3D-pharmacophores: The scoring function challenge. Drug Discovery Today: Technologies 7: e229–e236.

    Article  CAS  Google Scholar 

  • Hopfinger, A.J., A. Reaka, P. Venkatarangan, J.S. Duca, and S. Wang. 1999. Construction of a virtual high throughput screen by 4D-QSAR analysis: Application to a combinatorial library of glucose inhibitors of glycogen phosphorylase b. Journal of Chemical Information and Computer Sciences 39: 1151–1160.

    Article  CAS  Google Scholar 

  • Huang, N., B.K. Shoichet, and J.J. Irwin. 2006. Benchmarking sets for molecular docking. Journal of Medicinal Chemistry 49: 6789–6801.

    Article  PubMed  CAS  Google Scholar 

  • Ibrahim, M.A., A.G. Shilabin, S. Prasanna, M. Jacob, S.I. Khan, R.J. Doerksen, and M.T. Hamann. 2008. 2-N-methyl modifications and SAR studies of manzamine A. Bioorganic and Medicinal Chemistry 16: 6702–6706.

    Article  PubMed  CAS  Google Scholar 

  • Indarte, M., J.D. Madura, and C.K. Surratt. 2007. Dopamine transporter comparative molecular modeling and binding site prediction using the LeuTAa leucine transporter as a template. Proteins: Structure, Function, and Bioinformatics 70: 1033–1046.

    Article  CAS  Google Scholar 

  • Jain, A.N. 2003. Surflex: Fully automatic flexible molecular docking using a molecular similarity-based search engine. Journal of Medicinal Chemistry 46: 499–511.

    Article  PubMed  CAS  Google Scholar 

  • Jain, S., I. Abraham, P. Carvalho, Y.H. Kuang, L.A. Shaala, D.T. Youssef, M.A. Avery, Z.S. Chen, and K.A. El Sayed. 2009. Sipholane triterpenoids: Chemistry, reversal of ABCB1/P-glycoprotein-mediated multidrug resistance, and pharmacophore modeling. Journal of Natural Products 72: 1291–1298.

    Article  PubMed  CAS  Google Scholar 

  • Jang, J.-H., S.-C. Jeong, J.-H. Kim, Y.-H. Lee, Y.-C. Ju, and J.-S. Lee. 2011. Characterisation of a new antihypertensive angiotensin I-converting enzyme inhibitory peptide from Pleurotus cornucopiae. Food Chemistry 127: 412–418.

    Article  CAS  Google Scholar 

  • Jansen, J.M., and E.J. Martin. 2004. Target-biased scoring approaches and expert systems in structure-based virtual screening. Current Opinion in Chemical Biology 8: 359–364.

    Article  PubMed  CAS  Google Scholar 

  • Jimsheena, V.K., and L.R. Gowda. 2010. Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: Structure-activity relationship. Peptides 31: 1165–1176.

    Article  PubMed  CAS  Google Scholar 

  • Jimsheena, V.K., and L.R. Gowda. 2011. Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion. Food Chemistry 125: 561–569.

    Article  CAS  Google Scholar 

  • John, S., S. Thangapandian, S. Sakkiah, and K.W. Lee. 2011. Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies. BMC Bioinformatics 12: S1–S28.

    Article  Google Scholar 

  • Jones, G., P. Willett, R.C. Glen, A.R. Leach, and R. Taylor. 1997. Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology 267: 727–748.

    Article  PubMed  CAS  Google Scholar 

  • Jung, H.A., S.K. Hyun, H.R. Kim, and J.S. Choi. 2006. Angiotensin-converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera. Fisheries Science 72: 1292–1299.

    Article  CAS  Google Scholar 

  • Jung, H.A., S.H. Oh, and J.S. Choi. 2010. Molecular docking studies of phlorotannins from Eisenia bicyclis with BACE1 inhibitory activity. Bioorganic and Medicinal Chemistry Letters 20: 3211–3215.

    Article  PubMed  CAS  Google Scholar 

  • Kahnberg, P., M.H. Howard, T. Liljefors, M. Nielsen, E.O. Nielsen, O. Sterner, and I. Pettersson. 2004. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor. Journal of Molecular Graphics and Modelling 23: 253–261.

    Article  PubMed  CAS  Google Scholar 

  • Kassel, D.B. 2004. Applications of high-throughput ADME in drug discovery. Current Opinion in Chemical Biology 8: 339–345.

    Article  PubMed  CAS  Google Scholar 

  • Keseru, G.M., and G.M. Makara. 2006. Hit discovery and hit-to-lead approaches. Drug Discovery Today 11: 741–748.

    Article  PubMed  Google Scholar 

  • Khanfar, M.A., B.A. Asal, M. Mudit, A. Kaddoumi, and K.A. El Sayed. 2009. The marine natural-derived inhibitors of glycogen synthase kinase-3β phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling. Bioorganic and Medicinal Chemistry 17: 6032–6039.

    Article  PubMed  CAS  Google Scholar 

  • Khanfar, M.A., R.A. Hill, A. Kaddoumi, and K.A. El Sayed. 2010. Discovery of novel GSK-3beta inhibitors with potent in vitro and in vivo activities and excellent brain permeability using combined ligand- and structure-based virtual screening. Journal of Medicinal Chemistry 53: 8534–8545.

    Article  PubMed  CAS  Google Scholar 

  • Kim, A., T. Shin, M. Lee, J. Park, K. Park, N. Yoon, J. Kim, J. Choi, B. Jang, D. Byun, N. Park, and H. Kim. 2009. Isolation and identification of phlorotannins from Ecklonia stolonifera with antioxidant and anti-inflammatory properties. Journal of Agricultural and Food Chemistry 57: 3483–3489.

    Article  PubMed  CAS  Google Scholar 

  • Kirchmair, J., P. Markt, S. Distinto, G. Wolber, and T. Langer. 2008. Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection–what can we learn from earlier mistakes? Journal of Computer-Aided Molecular Design 22: 213–228.

    Article  PubMed  CAS  Google Scholar 

  • Klabunde, T., and A. Evers. 2005. GPCR antitarget modeling: Pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects. ChemBioChem: A European Journal of Chemical Biology 6: 876–889.

    Article  CAS  Google Scholar 

  • Koch, M.A., L.O. Wittenberg, S. Basu, D.A. Jeyaraj, E. Gourzoulidou, K. Reinecke, A. Odermatt, and H. Waldmann. 2004. Compound library development guided by protein structure similarity clustering and natural product structure. Proceedings of the National Academy of Sciences of the United States of America 101: 16721–16726.

    Article  PubMed  CAS  Google Scholar 

  • Kortagere, S., and S. Ekins. 2010. Troubleshooting computational methods in drug discovery. Journal of Pharmacological and Toxicological Methods 61: 67–75.

    Article  PubMed  CAS  Google Scholar 

  • Krishnaiah, P., V.L. Reddy, G. Venkataramana, K. Ravinder, M. Srinivasulu, T.V. Raju, K. Ravikumar, D. Chandrasekar, S. Ramakrishna, and Y. Venkateswarlu. 2004. New lamellarin alkaloids from the Indian ascidian Didemnum obscurum and their antioxidant properties. Journal of Natural Products 67: 1168–1171.

    Article  PubMed  CAS  Google Scholar 

  • Kroemer, R.T., A. Vulpetti, J.J. McDonald, D.C. Rohrer, J.Y. Trosset, F. Giordanetto, S. Cotesta, C. McMartin, M. Kihlen, and P.F. Stouten. 2004. Assessment of docking poses: Interactions-based accuracy classification (IBAC) versus crystal structure deviations. Journal of Chemical Information and Computer Sciences 44: 871–881.

    Article  PubMed  CAS  Google Scholar 

  • Lei, J., and J. Zhou. 2002. A marine natural product database. Journal of Chemical Information and Computer Sciences 42: 742–748.

    Article  PubMed  CAS  Google Scholar 

  • Levesque, M.J., K. Ichikawa, S. Date, and J.H. Haga. 2009. Design of a grid service-based platform for in silico protein-ligand screenings. Computer Methods and Programs in Biomedicine 93: 73–82.

    Article  PubMed  Google Scholar 

  • Li, G.-H., G.-W. Le, Y.-H. Shi, and S. Shrestha. 2004. Angiotensin I–converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutrition Research 24: 469–486.

    CAS  Google Scholar 

  • Li, X., F. Lu, Q. Tian, Y. Yang, Q. Wang, and J.Z. Wang. 2006. Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture. Journal of Neural Transmission 113: 93–102.

    Article  PubMed  CAS  Google Scholar 

  • LigandScout, Inte: Ligand GmbH, Vienna, Austria, Europe.

    Google Scholar 

  • Lipinski, C.A., F. Lombardo, B.W. Dominy, and P.J. Feeney. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 46: 3–26.

    Article  PubMed  CAS  Google Scholar 

  • Liu, X., S. Ouyang, B. Yu, Y. Liu, K. Huang, J. Gong, S. Zheng, Z. Li, H. Li, and H. Jiang. 2010. PharmMapper server: D web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Research 38: W609–614.

    Article  PubMed  CAS  Google Scholar 

  • Lizcano, F., C. Romero, and D. Vargas. 2011. Regulation of adipogenesis by nuclear receptor PPAR gamma is modulated by the histone demethylase JMJD2C. Genetics and Molecular Biology 34: 19–24.

    Article  PubMed  CAS  Google Scholar 

  • Lyne, P.D., P.W. Kenny, D.A. Cosgrove, C. Deng, S. Zabludoff, J.J. Wendoloski, and S. Ashwell. 2004. Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening. Journal of Medicinal Chemistry 47: 1962–1968.

    Article  PubMed  CAS  Google Scholar 

  • Mang, C., S. Jakupovic, S. Schunk, H.D. Ambrosi, O. Schwarz, and J. Jakupovic. 2006. Natural products in combinatorial chemistry: An andrographolide-based library. Journal of Combinatorial Chemistry 8: 268–274.

    Article  PubMed  CAS  Google Scholar 

  • MarinLit. Marine Natural Product Bibliography Software. Christchurch, New Zealand: University of Cantebury.

    Google Scholar 

  • Martin, Y.C., M.G. Bures, E.A. Danaher, J. DeLazzer, I. Lico, and P.A. Pavlik. 1993. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. Journal of Computer-Aided Molecular Design 7: 83–102.

    Article  PubMed  CAS  Google Scholar 

  • Martinez, A., A. Castro, I. Dorronsoro, and M. Alonso. 2002. Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation. Medicinal Research Reviews 22: 373–384.

    Article  PubMed  CAS  Google Scholar 

  • Martins, J.P., E.G. Barbosa, K.F. Pasqualoto, and M.M. Ferreira. 2009. LQTA-QSAR: A new 4D-QSAR methodology. Journal of Chemical Information and Modeling 49: 1428–1436.

    Article  PubMed  CAS  Google Scholar 

  • McGann, M. 2011. FRED pose prediction and virtual screening accuracy. Journal of Chemical Information and Modeling 51: 578–596.

    Article  PubMed  CAS  Google Scholar 

  • McIntosh, M., L.J. Cruz, M.W. Hunkapiller, W.R. Gray, and B.M. Olivera. 1982. Isolation and structure of a peptide toxin from the marine snail Conus magus. Archives of Biochemistry and Biophysics 218: 329–334.

    Article  PubMed  CAS  Google Scholar 

  • Mishra, K.P., L. Ganju, M. Sairam, P.K. Banerjee, and R.C. Sawhney. 2008. A review of high throughput technology for the screening of natural products. Biomedicine & Pharmacotherapy 62: 94–98.

    Article  CAS  Google Scholar 

  • Mladenovic, M., M. Arnone, R.F. Fink, and B. Engels. 2009. Environmental effects on charge densities of biologically active molecules: Do molecule crystal environments indeed approximate protein surroundings? Journal of Physical Chemistry B 13: 5072–5082.

    Article  CAS  Google Scholar 

  • Molecular Operating Environment, Chemical Computing Group (CCG), Montreal, Canada.

    Google Scholar 

  • Morphy, R., and Z. Rankovic. 2005. Designed multiple ligands. An emerging drug discovery paradigm. Journal of Medicinal Chemistry 48: 6523–6543.

    Article  PubMed  CAS  Google Scholar 

  • Morris, G.M., D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, and A.J. Olson. 1998. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry 19: 1639–1662.

    Article  CAS  Google Scholar 

  • MTree, BioSolveIT Gmbh, Sankt Augustin, Germany.

    Google Scholar 

  • Muegge, I. 2000. A knowledge-based scoring function for protein-ligand interactions: Probing the reference state. Perspectives in Drug Discovery and Design 20: 99–114.

    Article  CAS  Google Scholar 

  • Mukherjee, P., P. Desai, A. Srivastava, B. Tekwani, and M. Avery. 2008. Probing the structures of leishmanial farnesyl pyrophosphate synthases: Homology modeling and docking studies. Journal of Chemical Information and Modeling 48: 1026–1040.

    Article  PubMed  CAS  Google Scholar 

  • Murray, C.W., and T.L. Blundell. 2010. Structural biology in fragment-based drug design. Current Opinion in Structural Biology 20: 497–507.

    Article  PubMed  CAS  Google Scholar 

  • Norinder, U., and C.A.S. Bergstrom. 2006. Prediction of ADMET properties. ChemMedChem 1: 920–937.

    Article  PubMed  CAS  Google Scholar 

  • Nwosu, F., J. Morris, V.A. Lund, D. Stewart, H.A. Ross, and G.J. McDougall. 2011. Anti-proliferative and potential anti-diabetic effects of phenolic-rich extracts from edible marine algae. Food Chemistry 126: 1006–1012.

    Article  CAS  Google Scholar 

  • Ono, S., M. Hosokawa, K. Miyashita, and K. Takahashi. 2006. Isolation of peptides with angiotensin I-converting enzyme inhibitory effect derived from hydrolysate of upstream Chum Salmon Muscle. Journal of Food Science 68: 1611–1614.

    Article  Google Scholar 

  • Oprea, T.I., and H. Matter. 2004. Integrating virtual screening in lead discovery. Current Opinion in Chemical Biology 8: 349–358.

    Article  PubMed  CAS  Google Scholar 

  • Parys, S., S. Kehraus, A. Krick, K.W. Glombitza, S. Carmeli, K. Klimo, C. Gerhauser, and G.M. Konig. 2010. In vitro chemopreventive potential of fucophlorethols from the brown alga Fucus vesiculosus L. by anti-oxidant activity and inhibition of selected cytochrome P450 enzymes. Phytochemistry 71: 221–229.

    Article  PubMed  CAS  Google Scholar 

  • Patel, S., and C.L. Brooks III. 2006. Fluctuating charge force fields: Recent developments and applications from small molecules to macromolecular biological systems. Molecular Simulation 32: 231–249.

    Article  CAS  Google Scholar 

  • Peach, M.L., and M.C. Nicklaus. 2009. Combining docking with pharmacophore filtering for improved virtual screening. Journal of Cheminformatics 1: 6.

    Article  PubMed  CAS  Google Scholar 

  • Pelish, H.E., N.J. Westwood, Y. Feng, T. Kirchhausen, and M.D. Shair. 2001. Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product. Journal of the American Chemical Society 123: 6740–6741.

    Article  PubMed  CAS  Google Scholar 

  • QSAR World. 2007. Strand Life Sciences Pvt. Ltd., http://www.qsarworld.com/. Accessed 3 May 2011.

  • Queiroz, A.N., B.A.Q. Gomes, W.M. Moraes Jr., and R.S. Borges. 2009. A theoretical antioxidant pharmacophore for resveratrol. European Journal of Medicinal Chemistry 44: 1644–1649.

    Article  PubMed  CAS  Google Scholar 

  • Raha, K., M.B. Peters, B. Wang, N. Yu, A.M. Wollacott, L.M. Westerhoff, and K.M. Merz Jr. 2007. The role of quantum mechanics in structure-based drug design. Drug Discovery Today 12: 725–731.

    Article  PubMed  CAS  Google Scholar 

  • Reddy, M.V., M.R. Rao, D. Rhodes, M.S. Hansen, K. Rubins, F.D. Bushman, Y. Venkateswarlu, and D.J. Faulkner. 1999. Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture. Journal of Medicinal Chemistry 42: 1901–1907.

    Article  PubMed  CAS  Google Scholar 

  • Rella, M., C.A. Rushworth, J.L. Guy, A.J. Turner, T. Langer, and R.M. Jackson. 2006. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors. Journal of Chemical Information and Modeling 46: 708–716.

    Article  PubMed  CAS  Google Scholar 

  • Reymond, J.L., R. van Deursen, L.C. Blum, and L. Ruddigkeit. 2010. Chemical space as a source for new drugs. Medicinal Chemistry Communications 1: 30–38.

    Article  CAS  Google Scholar 

  • Rinehart, K.L., T.G. Holt, N.L. Fregeau, J.G. Stroh, P.A. Keifer, F. Sun, L.H. Li, and D.G. Martin. 1990. Ecteinascidins 729, 743, 745, 759A, 759B, and 770: Potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. Journal of Organic Chemistry 55: 4512–4515.

    Article  CAS  Google Scholar 

  • Ripphausen, P., B. Nisius, L. Peltason, and J. Bajorath. 2010. Quo vadis, virtual screening? A comprehensive survey of prospective applications. Journal of Medicinal Chemistry 53: 8461–8467.

    Article  PubMed  CAS  Google Scholar 

  • Ritchie, T.J., P. Ertl, and R. Lewis. 2011. The graphical representation of ADME-related molecule properties for medicinal chemists. Drug Discovery Today 16: 65–72.

    Article  PubMed  CAS  Google Scholar 

  • Rollinger, J.M. 2009. Accessing target information by virtual parallel screening – The impact on natural product research. Phytochemistry Letters 2: 53–58.

    Article  CAS  Google Scholar 

  • Rollinger, J.M., A. Hornick, T. Langer, H. Stuppner, and H. Prast. 2004. Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products. Journal of Medicinal Chemistry 47: 6248–6254.

    Article  PubMed  CAS  Google Scholar 

  • Sakai, R., T. Higa, C.W. Jefford, and G. Bernardinelli. 1986. Manzamine A, a novel antitumor alkaloid from a sponge. Journal of the American Chemical Society 108: 6404–6405.

    Article  CAS  Google Scholar 

  • Samantray, D., and R.K. Sahu. 2010. Drug designing and docking efficacy assessment of halogen substituted aspirin. Researcher 2: 17–23.

    Google Scholar 

  • Sato, M., T. Hosokawa, T. Yamaguchi, N. Toshiki, K. Muramoto, T. Kahara, K. Funayama, A. Kobayashi, and T. Nakano. 2002. Angiotensin I-converting enzyme inhibitory peptides derived from Wakame (Undaria pinnatifida) and their antihypertensive effect in spontaneously hypertensive Rats. Journal of Agricultural and Food Chemistry 50: 6245–6252.

    Article  PubMed  CAS  Google Scholar 

  • Schneidman-Duhovny, D., O. Dror, Y. Inbar, R. Nussinov, and H.J. Wolfson. 2008. PharmaGist: A webserver for ligand-based pharmacophore detection. Nucleic Acids Research 36: W223–W228. Catalyst, Accelrys Inc., San Diego, CA.

    Article  PubMed  CAS  Google Scholar 

  • Schuster, D. 2010. 3D pharmacophores as tools for activity profiling. Drug Discovery Today: Technologies 7: e205–e211.

    Article  CAS  Google Scholar 

  • Segura Campos, M.R., L.A. Chel Guerrero, and D.A. Betancur Ancona. 2010. Angiotensin-I converting enzyme inhibitory and antioxidant activities of peptide fractions extracted by ultrafiltration of cowpea Vigna unguiculata hydrolysates. Journal of the Science of Food and Agriculture 90: 2512–2518.

    Article  PubMed  CAS  Google Scholar 

  • Selnergy, Greenpharma S.A.S, Orléans, France.

    Google Scholar 

  • Senese, C.L., J. Duca, D. Pan, A.J. Hopfinger, and Y.J. Tseng. 2004. 4D-fingerprints, universal QSAR and QSPR descriptors. Journal of Chemical Information and Computer Sciences 44: 1526–1539.

    Article  PubMed  CAS  Google Scholar 

  • Sepe, V., G. Bifulco, B. Renga, C. D’Amore, S. Fiorucci, and A. Zampella. 2011. Discovery of sulfated sterols from marine invertebrates as a new class of marine natural antagonists of farnesoid-x-receptor. Journal of Medicinal Chemistry 54: 1314–1320.

    Article  PubMed  CAS  Google Scholar 

  • Shibata, T., K. Ishimaru, S. Kawaguchi, H. Yoshikawa, and Y. Hama. 2008. Antioxidant activities of phlorotannins isolated from Japanese Laminariaceae. Journal of Applied Phycology 20: 705–711.

    Article  CAS  Google Scholar 

  • Shu, Y.Z. 1998. Recent natural products based drug development: A pharmaceutical industry perspective. Journal of Natural Products 61: 1053–1071.

    Article  PubMed  CAS  Google Scholar 

  • Srinivas, E., J.N. Murthy, A.R.R. Rao, and G.N. Sastry. 2006. Recent advances in molecular modeling and medicinal chemistry aspects of phospho-glycoprotein. Current Drug Metabolism 7: 205–217.

    Article  PubMed  CAS  Google Scholar 

  • Stahl, M., and D. Rarey. 2001. Detailed analysis of scoring functions for virtual screening. Journal of Medicinal Chemistry 44: 1035–1042.

    Article  PubMed  CAS  Google Scholar 

  • Stahl, M., W. Guba, and M. Kansy. 2006. Integrating molecular design resources within modern drug discovery research: The Roche experience. Drug Discovery Today 11: 326–333.

    Article  PubMed  CAS  Google Scholar 

  • Steindl, T., and T. Langer. 2005. Docking versus pharmacophore model generation: A comparison of high-throughput virtual screening strategies for the search of human rhinovirus coat protein inhibitors. QSAR & Combinatorial Science 24: 470–479.

    Article  CAS  Google Scholar 

  • Strohl, W.R. 2000. The role of natural products in a modern drug discovery program. Drug Discovery Today 5: 39–41.

    Article  PubMed  Google Scholar 

  • Surflex-Dock 2.0, Tripos International, Missouri, USA.

    Google Scholar 

  • SYBYL 8.0, Tripos International, Missouri, USA.

    Google Scholar 

  • Taha, M.O., M. Tarairah, H. Zalloum, and G. Abu-Sheikha. 2010. Pharmacophore and QSAR modeling of estrogen receptor beta ligands and subsequent validation and in silico search for new hits. Journal of Molecular Graphics and Modelling 28: 383–400.

    Article  PubMed  CAS  Google Scholar 

  • Tawari, N.R., and M.S. Degani. 2010. Pharmacophore mapping and electronic feature analysis for a series of nitroaromatic compounds with antitubercular activity. Journal of Computational Chemistry 31: 739–751.

    PubMed  CAS  Google Scholar 

  • Thipnate, P., J. Liu, S. Hannongbua, and A.J. Hopfinger. 2009. 3D pharmacophore mapping using 4D QSAR analysis for the cytotoxicity of lamellarins against human hormone-dependent T47D breast cancer cells. Journal of Chemical Information and Modeling 49: 2312–2322.

    Article  PubMed  CAS  Google Scholar 

  • Thomsen, R., and M.H. Christensen. 2006. MolDock: A new technique for high-accuracy molecular docking. Journal of Medicinal Chemistry 49: 3315–3321.

    Article  PubMed  CAS  Google Scholar 

  • Tierney, M.S., A.K. Croft, and M. Hayes. 2010. A review of antihypertensive and antioxidant activities in macroalgae. Botanica Marina 53: 387–408.

    Article  CAS  Google Scholar 

  • Trindade-Silva, A.E., G.E. Lim-Fong, K.H. Sharp, and M.G. Haygood. 2010. Bryostatins: Biological context and biotechnological prospects. Current Opinion in Biotechnology 21: 834–842.

    Article  PubMed  CAS  Google Scholar 

  • Trott, O., and A.J. Olson. 2010. Software news and update AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry 31: 455–461.

    PubMed  CAS  Google Scholar 

  • US Environment Protection Agency, ECOTOX (ECOTOXicology) Database, Release 4.0. 2011. http://cfpub.epa.gov/ecotox/ecotox_home.cfm. Accessed 3 May 2011.

  • US Food and Drug Administration, Mold2, Descriptors Generator Software. 2010. US Department of Health and Human Services. http://www.fda.gov/ScienceResearch/BioinformaticsTools/Mold2/default.htm. Accessed 3 May 2011.

  • van de Waterbeemd, H., and E. Gifford. 2003. ADMET in silico modelling: Towards prediction paradise? Nature Reviews Drug Discovery 2: 192–204.

    Article  PubMed  CAS  Google Scholar 

  • Vanhuyse, M., J. Kluza, C. Tardy, G. Otero, C. Cuevas, C. Bailly, and A. Lansiaux. 2005. Lamellarin D: A novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux. Cancer Letters 221: 165–175.

    Article  PubMed  CAS  Google Scholar 

  • Verdonk, M.L., J.C. Cole, M.J. Hartshorn, C.W. Murray, and R.D. Taylor. 2003. Improved protein–ligand docking using GOLD. Proteins 52: 609–623.

    Article  PubMed  CAS  Google Scholar 

  • Viennois, E., A.J.C. Pommier, K. Mouzat, A. Oumeddour, F.Z. El Hajjaji, J. Dufour, F. Caira, D.H. Volle, S. Baron, and J.M.A. Lobaccaro. 2011. Targeting liver X receptors in human health: Deadlock or promising trail? Expert Opinion on Therapeutic Targets 15: 219–232.

    Article  PubMed  CAS  Google Scholar 

  • von Korff, M., C. Rufener, M. Stritt, J. Freyss, R. Bar, and T. Sander. 2011. Integration of distributed computing into the drug discovery process. Expert Opinion on Drug Discovery 6: 103–107.

    Article  CAS  Google Scholar 

  • Wald, C. 2010. Scientists Embrace Openness. Science Careers. doi:10.1126/science.caredit.a1000036.

  • Wallach, I., and R. Lilien. 2011. Virtual decoy sets for molecular docking benchmarks. Journal of Chemical Information and Modeling 51: 196–202.

    Article  PubMed  CAS  Google Scholar 

  • Wang, R., and S. Wang. 2001. How does consensus scoring work for virtual library screening? An idealized computer experiment. Journal of Chemical Information and Computer Sciences 41: 1422–1426.

    Article  PubMed  CAS  Google Scholar 

  • Wang, H.B., J. Chen, K. Hollister, L.C. Sowers, and B.M. Forman. 1999. Endogenous bile acids are ligands for the nuclear receptor FXR BAR. Molecular Cell 3: 543–553.

    Article  PubMed  CAS  Google Scholar 

  • Wang, R., Y. Lu, and S. Wang. 2003. Comparative evaluation of 11 scoring functions for molecular docking. Journal of Medicinal Chemistry 46: 2287–2303.

    Article  PubMed  CAS  Google Scholar 

  • Wang, Z., B. Ling, R. Zhang, Y. Suo, Y. Liu, Z. Yu, and C. Liu. 2009. Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase. Journal of Molecular Graphics and Modelling 28: 162–169.

    Article  PubMed  CAS  Google Scholar 

  • Wang, Z., S. Zhang, W. Wang, F. Feng, and W. Shan. 2011. A novel angiotensin I converting enzyme inhibitory peptide from the milk casein: Virtual screening and docking studies. Agricultural Sciences in China 10: 463–467.

    Article  CAS  Google Scholar 

  • Warren, G.L., C.W. Andrews, A.M. Capelli, B. Clarke, J. LaLonde, M.H. Lambert, M. Lindvall, N. Nevins, S.F. Semus, S. Senger, G. Tedesco, I.D. Wall, J.M. Woolven, C.E. Peishoff, and M.S. Head. 2006. A critical assessment of docking programs and scoring functions. Journal of Medicinal Chemistry 49: 5912–5931.

    Article  PubMed  CAS  Google Scholar 

  • Watson, P., Leahy, D., Cala, J., Searson, D., Sykora, V., Taylor, M., Woodman, S., Hiden, H., OpenQSAR. 2010. School of Computing Science, Newcastle University. http://www.openqsar.com/, Accessed 3 May 2011.

  • Welch, W., J. Ruppert, and A.N. Jain. 1996. Hammerhead: Fast, fully automated docking of flexible ligands to protein binding sites. Chemistry and Biology 3: 449–462.

    Article  PubMed  CAS  Google Scholar 

  • Wender, P.A., C.M. Cribbs, K.F. Koehler, N.A. Sharkey, C.L. Herald, Y. Kamano, G.R. Pettit, and P.M. Blumberg. 1988. Modeling of the Bryostatins to the phorbol ester pharmacophore on protein kinase-C. Proceedings of the National Academy of Sciences of the United States of America 85: 7197–7201.

    Article  PubMed  CAS  Google Scholar 

  • Wijesekara, I., and S.K. Kim. 2010. Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: Prospects in the pharmaceutical industry. Marine Drugs 8: 1080–1093.

    Article  PubMed  CAS  Google Scholar 

  • Williams, A., Chemspider. 2011. Royal Society of Chemistry. http://www.chemspider.com/. Accessed 3 May 2011.

  • Willighagen, E., Guha, R., Steinbeck, C., Chemistry Development Kit. 2011. Sourceforge. http://sourceforge.net/projects/cdk/. Accessed 3 May 2011.

  • Wolber, G., and T. Langer. 2005. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling 45: 160–169.

    Article  PubMed  CAS  Google Scholar 

  • World Community Grid, World Community Grid, technology solving problems. 2011. IBM. http://www.worldcommunitygrid.org/. Accessed 3 May 11.

  • Wunberg, T., M. Hendrix, A. Hillisch, M. Lobell, H. Meier, C. Schmeck, H. Wild, and B. Hinzen. 2006. Improving the hit-to-lead process: Data-driven assessment of drug-like and lead-like screening hits. Drug Discovery Today 11: 175–180.

    Article  PubMed  CAS  Google Scholar 

  • Yap, T.A., C.P. Carden, and S.B. Kaye. 2009. Beyond chemotherapy: Targeted therapies in ovarian cancer. Nature Reviews Cancer 9: 167–181.

    Article  PubMed  CAS  Google Scholar 

  • Zhou, Z., A.K. Felts, R.A. Friesner, and R.M. Levy. 2007. Comparative performance of several flexible docking programs and scoring functions: Enrichment studies for a diverse set of pharmaceutically relevant targets. Journal of Chemical Information and Modeling 47: 1599–1608.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. K. Croft .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Croft, A.K., Groenewald, W., Tierney, M.S. (2012). Medicinal Chemistry and Ligand Profiling for Evaluation of Promising Marine Bioactive Molecules. In: Hayes, M. (eds) Marine Bioactive Compounds. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-1247-2_7

Download citation

Publish with us

Policies and ethics